Combined pharmacologic treatment with clopidogrel and statin for patients with acute coronary syndrome: Is there a survival advantage? [3] (multiple letters)
10.1093/eurheartj/ehi434
Saved in:
Main Authors: | Almsherqi, Z., Deng, Y., Mclachlan, C., Mossop, P.J., Lim, M.J., Mehta, R.H. |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Others |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/24997 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2016) -
Evaluation of clopidogrel resistance [3]
by: Almsherqi, Z.A., et al.
Published: (2011) -
Interpretation of clopidogrel resistance (multiple letters)
by: Almsherqi, Z.A., et al.
Published: (2014) -
Interpretation of clopidogrel resistance (multiple letters)
by: Almsherqi, Z.A., et al.
Published: (2016)